Table 1.

Allele and genotype frequencies of 5 SNPs in GGEs patients (n = 484) and healthy controls (n = 284)

SNP	Genotype/allele	GGEs	Controls	Crude	Additive		Dominant		Recessive
		n (%)	n (%)	P	P	OR(95%) CI	P	OR (95%) CI	P	OR (95%) CI
rs13026414	TT	7.7	5.3	0.44	0.199	1.51 (0.81–2.83)	0.516	1.11 (0.82–1.49)	0.207	1.22 (0.90–1.66)
	CT	32.8	32.9
	CC	59.5	61.8
	T	24.1	21.7	0.286
	C	75.9	78.3
rs72823592	AA	0.4	0	0.41	NA	NA	0.242	3.55 (0.43–29.66)	NA	NA
	AG	0.8	0.4
	GG	98.8	99.6
	A	0.8	0.2	0.107
	G	99.2	99.8
rs10496964	TT	1.5	2.8	0.4	0.188	0.50 (0.18–1.40)	0.586	0.92 (0.66–1.26)	0.195	0.71 (0.43–1.19)
	CT	27.3	27.8
	CC	71.2	69.4
	T	15.1	16.7	0.402
	C	84.9	83.3
rs11890028	GG	1.7	2.1	0.77	0.624	0.77 (0.26–2.24)	0.506	0.89 (0.64–1.25)	0.655	0.89 (0.52–1.51)
	GT	22.2	23.9
	TT	76.1	74
	G	12.8	14.1	0.469
	T	87.2	85.9
rs12059546	GG	11	10.9	0.41	0.781	0.93 (0.57–1.53)	0.176	0.82 (0.61–1.09)	0.944	0.99 (0.78–1.25)
	AG	39.6	44.4
	AA	49.4	44.7
	G	31	33.1	0.364
	A	69	66.9

OR, odds ratio; CI, confidence interval; SNP, single nucleotide polymorphism; GGEs, Genetic generalized epilepsies.